Mark Diamond

Mark Diamond

Presidente en DIMERIX LIMITED .
Health Technology
Consumer Services
Distribution Services

Perfil

Mark Diamond is currently Non-Executive Chairman at Dimerix Ltd. since 2023 and Non-Executive Director at Arovella Therapeutics Ltd. starting in 2026.
Former roles include Chief Executive Officer & Executive Director at Percheron Therapeutics Ltd. from 2010 to 2023, Director-Project Planning & Business Development at Alpharma Specialty Pharma LLC, Manager-International Business Development at FH Faulding & Co. Ltd., and Senior Manager-Business Development at Faulding Pharmaceuticals Plc.
Education includes an undergraduate degree from Monash University and an MBA from Macquarie University.

Cargos activos de Mark Diamond

EmpresasCargoInicio
DIMERIX LIMITED Presidente 12/01/2023
AROVELLA THERAPEUTICS LIMITED Director/Miembro de la Junta 28/04/2026

Antiguos cargos conocidos de Mark Diamond.

EmpresasCargoFin
PERCHERON THERAPEUTICS LIMITED Director Ejecutivo 12/05/2023
Corporate Officer/Principal -
Faulding Pharmaceuticals Plc
Corporate Officer/Principal -
Corporate Officer/Principal -
Ver el detalle de la experiencia de Mark Diamond.

Formación de Mark Diamond.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

38

Relaciones de 1er grado

8

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas8

Distribution Services

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

Faulding Pharmaceuticals Plc

40% de descuento. Las herramientas más útiles solo para suscriptores: ¡descubre las mejores inversiones del futuro!
d
:
:
APROVECHAR LA PROMOCIÓN